Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM – Get Rating) shares traded down 6.6% during trading on Friday . The company traded as low as C$0.29 and last traded at C$0.29. 4,800 shares changed hands during mid-day trading, an increase of 68% from the average session volume of 2,858 shares. The stock had previously closed at C$0.31.
Zomedica Pharmaceuticals Corp. (ZOM.V) Stock Performance
The company has a debt-to-equity ratio of 4.91, a quick ratio of 15.25 and a current ratio of 15.31. The business has a 50-day moving average price of C$0.29 and a 200 day moving average price of C$0.28. The stock has a market capitalization of C$36.73 million and a P/E ratio of -2.61.
Zomedica Pharmaceuticals Corp. (ZOM.V) Company Profile
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and related companies with MarketBeat.com's FREE daily email newsletter.